Advanced Bionics, FDA reach settlement
This article was originally published in The Silver Sheet
Executive Summary
Cochlear implant maker Advanced Bionics has settled with FDA over agency allegations that the firm violated quality system regulations and failed to properly submit a PMA supplement when it added a vendor for a component of its HiRes90K implant ("The Silver Sheet" May 2008). Under the July 14 agreement, neither Advanced Bionics nor CEO Jeff Greiner admits liability. However, the company will pay FDA a civil money penalty of $1.1 million, while Greiner will pay $75,000 - considerably less than the $2.2 million in fines the agency requested in its original complaint, filed in November 2007
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.